Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.470
+0.030 (1.23%)
At close: Nov 28, 2025, 1:00 PM EST
2.450
-0.020 (-0.81%)
After-hours: Nov 28, 2025, 4:51 PM EST
Iovance Biotherapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$10.36
Upside
+319.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $4 → $9 | Buy | Maintains | $4 → $9 | +264.37% | Nov 24, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +588.26% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $9 | Strong Buy | Maintains | $20 → $9 | +264.37% | Oct 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +709.72% | Aug 19, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $14 | Buy | Maintains | $18 → $14 | +466.80% | Aug 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +709.72% | Aug 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +912.15% | Jul 23, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $17 → $2 | Strong Buy → Hold | Downgrades | $17 → $2 | -19.03% | May 16, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $16 → $8 | Strong Buy | Maintains | $16 → $8 | +223.89% | May 12, 2025 |
| Mizuho | Mizuho | Buy Maintains $30 → $10 | Buy | Maintains | $30 → $10 | +304.86% | May 12, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +61.94% | May 12, 2025 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 → $25 | Strong Buy | Maintains | $30 → $25 | +912.15% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $20 | Strong Buy | Maintains | $32 → $20 | +709.72% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +547.77% | Apr 17, 2025 |
| Barclays | Barclays | Buy Maintains $22 → $5 | Buy | Maintains | $22 → $5 | +102.43% | Apr 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.